Progress in Neutron Capture Therapy for Cancer:
Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancer...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
1992
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. The degree of surgery possible may be limited by the critical nature of the organ, and chemotherapy and radiotherapy are of palliative value only. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumours should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions. The first symposium on NCT was held in Boston in 1983, followed by Tokyo in 1985 and Bremen, Germany in 1988 |
| Beschreibung: | 1 Online-Ressource (XXXI, 668 p) |
| ISBN: | 9781461533849 |
| DOI: | 10.1007/978-1-4615-3384-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046143542 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1992 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461533849 |9 978-1-4615-3384-9 | ||
| 024 | 7 | |a 10.1007/978-1-4615-3384-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4615-3384-9 | ||
| 035 | |a (OCoLC)1119008444 | ||
| 035 | |a (DE-599)BVBBV046143542 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XH 3305 |0 (DE-625)152889:13134 |2 rvk | ||
| 245 | 1 | 0 | |a Progress in Neutron Capture Therapy for Cancer |c edited by Barry J. Allen, Douglas E. Moore, Baiba V. Harrington |
| 264 | 1 | |a Boston, MA |b Springer US |c 1992 | |
| 300 | |a 1 Online-Ressource (XXXI, 668 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. The degree of surgery possible may be limited by the critical nature of the organ, and chemotherapy and radiotherapy are of palliative value only. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumours should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions. The first symposium on NCT was held in Boston in 1983, followed by Tokyo in 1985 and Bremen, Germany in 1988 | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Nuclear Medicine | |
| 650 | 4 | |a Ultrasound | |
| 650 | 4 | |a Animal Anatomy / Morphology / Histology | |
| 650 | 4 | |a Plant Sciences | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Nuclear medicine | |
| 650 | 4 | |a Diagnosis, Ultrasonic | |
| 650 | 4 | |a Morphology (Animals) | |
| 650 | 4 | |a Botany | |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neutroneneinfangtherapie |0 (DE-588)4596398-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1990 |z Sydney |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Neutroneneinfangtherapie |0 (DE-588)4596398-8 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Allen, Barry J. |4 edt | |
| 700 | 1 | |a Moore, Douglas E. |4 edt | |
| 700 | 1 | |a Harrington, Baiba V. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306441042 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461364948 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461533856 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-3384-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031523727 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-1-4615-3384-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180477710434304 |
|---|---|
| any_adam_object | |
| author2 | Allen, Barry J. Moore, Douglas E. Harrington, Baiba V. |
| author2_role | edt edt edt |
| author2_variant | b j a bj bja d e m de dem b v h bv bvh |
| author_facet | Allen, Barry J. Moore, Douglas E. Harrington, Baiba V. |
| building | Verbundindex |
| bvnumber | BV046143542 |
| classification_rvk | XH 3305 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4615-3384-9 (OCoLC)1119008444 (DE-599)BVBBV046143542 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4615-3384-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03812nmm a2200637zc 4500</leader><controlfield tag="001">BV046143542</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1992 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461533849</subfield><subfield code="9">978-1-4615-3384-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-3384-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4615-3384-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119008444</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046143542</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3305</subfield><subfield code="0">(DE-625)152889:13134</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Progress in Neutron Capture Therapy for Cancer</subfield><subfield code="c">edited by Barry J. Allen, Douglas E. Moore, Baiba V. Harrington</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXXI, 668 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. The degree of surgery possible may be limited by the critical nature of the organ, and chemotherapy and radiotherapy are of palliative value only. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumours should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions. The first symposium on NCT was held in Boston in 1983, followed by Tokyo in 1985 and Bremen, Germany in 1988</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ultrasound</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Animal Anatomy / Morphology / Histology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Plant Sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnosis, Ultrasonic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Morphology (Animals)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Botany</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neutroneneinfangtherapie</subfield><subfield code="0">(DE-588)4596398-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1990</subfield><subfield code="z">Sydney</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neutroneneinfangtherapie</subfield><subfield code="0">(DE-588)4596398-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allen, Barry J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moore, Douglas E.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harrington, Baiba V.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306441042</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461364948</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461533856</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-3384-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031523727</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-3384-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 1990 Sydney gnd-content |
| genre_facet | Konferenzschrift 1990 Sydney |
| id | DE-604.BV046143542 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:23Z |
| institution | BVB |
| isbn | 9781461533849 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031523727 |
| oclc_num | 1119008444 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XXXI, 668 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Springer US |
| record_format | marc |
| spelling | Progress in Neutron Capture Therapy for Cancer edited by Barry J. Allen, Douglas E. Moore, Baiba V. Harrington Boston, MA Springer US 1992 1 Online-Ressource (XXXI, 668 p) txt rdacontent c rdamedia cr rdacarrier Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. The degree of surgery possible may be limited by the critical nature of the organ, and chemotherapy and radiotherapy are of palliative value only. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumours should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions. The first symposium on NCT was held in Boston in 1983, followed by Tokyo in 1985 and Bremen, Germany in 1988 Oncology Nuclear Medicine Ultrasound Animal Anatomy / Morphology / Histology Plant Sciences Oncology Nuclear medicine Diagnosis, Ultrasonic Morphology (Animals) Botany Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Neutroneneinfangtherapie (DE-588)4596398-8 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1990 Sydney gnd-content Krebs Medizin (DE-588)4073781-0 s Neutroneneinfangtherapie (DE-588)4596398-8 s 2\p DE-604 Allen, Barry J. edt Moore, Douglas E. edt Harrington, Baiba V. edt Erscheint auch als Druck-Ausgabe 9780306441042 Erscheint auch als Druck-Ausgabe 9781461364948 Erscheint auch als Druck-Ausgabe 9781461533856 https://doi.org/10.1007/978-1-4615-3384-9 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Progress in Neutron Capture Therapy for Cancer Oncology Nuclear Medicine Ultrasound Animal Anatomy / Morphology / Histology Plant Sciences Oncology Nuclear medicine Diagnosis, Ultrasonic Morphology (Animals) Botany Krebs Medizin (DE-588)4073781-0 gnd Neutroneneinfangtherapie (DE-588)4596398-8 gnd |
| subject_GND | (DE-588)4073781-0 (DE-588)4596398-8 (DE-588)1071861417 |
| title | Progress in Neutron Capture Therapy for Cancer |
| title_auth | Progress in Neutron Capture Therapy for Cancer |
| title_exact_search | Progress in Neutron Capture Therapy for Cancer |
| title_full | Progress in Neutron Capture Therapy for Cancer edited by Barry J. Allen, Douglas E. Moore, Baiba V. Harrington |
| title_fullStr | Progress in Neutron Capture Therapy for Cancer edited by Barry J. Allen, Douglas E. Moore, Baiba V. Harrington |
| title_full_unstemmed | Progress in Neutron Capture Therapy for Cancer edited by Barry J. Allen, Douglas E. Moore, Baiba V. Harrington |
| title_short | Progress in Neutron Capture Therapy for Cancer |
| title_sort | progress in neutron capture therapy for cancer |
| topic | Oncology Nuclear Medicine Ultrasound Animal Anatomy / Morphology / Histology Plant Sciences Oncology Nuclear medicine Diagnosis, Ultrasonic Morphology (Animals) Botany Krebs Medizin (DE-588)4073781-0 gnd Neutroneneinfangtherapie (DE-588)4596398-8 gnd |
| topic_facet | Oncology Nuclear Medicine Ultrasound Animal Anatomy / Morphology / Histology Plant Sciences Oncology Nuclear medicine Diagnosis, Ultrasonic Morphology (Animals) Botany Krebs Medizin Neutroneneinfangtherapie Konferenzschrift 1990 Sydney |
| url | https://doi.org/10.1007/978-1-4615-3384-9 |
| work_keys_str_mv | AT allenbarryj progressinneutroncapturetherapyforcancer AT mooredouglase progressinneutroncapturetherapyforcancer AT harringtonbaibav progressinneutroncapturetherapyforcancer |